Abemaciclib in Patients with Oligodendroglioma

Clinical trial NCT03969706 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03969706
Sponsor: Stephen Bagley, MD, MSCE
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Oligodendroglioma, Adult

Start date: 2019-05-15
Primary completion: 2025-05-15
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.